Dapper-1 is essential for Wnt5a induced cardiomyocyte hypertrophy by regulating the Wnt/PCP pathway

FEBS Letters

Volumn 588, Issue 14, 2014, Pages 2230-2237

  Hagenmueller, Marco ^a   Riffel, Johannes H ^a   Bernhold, Elmar ^a   Fan, Jingjing ^a   Katus, Hugo A ^a,b   Hardt, Stefan E ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Cardiomyocyte hypertrophy; Wnt Signaling

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DAPPER 1 PROTEIN; MEMBRANE RECEPTOR; PROTEIN KINASE C; RYANODINE RECEPTOR 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VAN GOGH LIKE 2 PROTEIN; WNT PROTEIN; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL POLARITY; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; ENZYME PHOSPHORYLATION; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CARDIOMYOCYTE HYPERTROPHY; WNT SIGNALING;

ANIMALS; CARDIOMEGALY; CELL SIZE; CELLS, CULTURED; CYTOPLASMIC VESICLES; MAP KINASE SIGNALING SYSTEM; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NUCLEAR PROTEINS; PROTEIN TRANSPORT; RATS; RATS, WISTAR; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84902651337     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.05.039     Document Type: Article

References (22)

1. N. Frey, H.A. Katus, E.N. Olson, and J.A. Hill Hypertrophy of the heart: a new therapeutic target? Circulation 109 2004 1580 1589
2. V.A. van de Schans, J.F. Smits, and W.M. Blankesteijn The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe? Eur. J. Pharmacol. 585 2008 338 345
3. M.W. Bergmann WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development Circ. Res. 107 2010 1198 1208
4. W.M. Blankesteijn, V.A. van de Schans, P. ter Horst, and J.F. Smits The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy Trends Pharmacol. Sci. 29 2008 175 180
5. V.A. van de Schans et al. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy Hypertension 49 2007 473 480
6. A. Bejsovec Wnt pathway activation: new relations and locations Cell 120 2005 11 14
7. T. Buechling, and M. Boutros Wnt signaling signaling at and above the receptor level Curr. Top. Dev. Biol. 97 2011 21 53
8. C. Gao, and Y.G. Chen Dishevelled: the hub of Wnt signaling Cell Signal. 22 2010 717 727
9. C. Niehrs The complex world of WNT receptor signalling Nat. Rev. Mol. Cell Biol. 13 2012 767 779
10. R. Sugimura, and L. Li Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases Birth Defects Res. C Embryo Today 90 2010 243 256
11. B. Gao et al. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2 Dev. Cell 20 2011 163 176
12. M. Hagenmueller et al. Dapper-1 induces myocardial remodeling through activation of canonical Wnt signaling in cardiomyocytes Hypertension 61 2013 1177 1183
13. X. Gao, J. Wen, L. Zhang, X. Li, Y. Ning, A. Meng, and Y.G. Chen Dapper1 is a nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus J. Biol. Chem. 283 2008 35679 35688
14. M. Hagenmueller, P. Malekar, C. Fieger, C.S. Weiss, S.J. Buss, D. Wolf, H.A. Katus, and S.E. Hardt Depletion of mammalian target of rapamycin (mTOR) via siRNA mediated knockdown leads to stabilization of beta-catenin and elicits distinct features of cardiomyocyte hypertrophy FEBS Lett. 584 2010 74 80
15. S.L. McDonald, and A. Silver The opposing roles of Wnt-5a in cancer Br. J. Cancer 101 2009 209 214
16. Y. Wang, B. Su, V.P. Sah, J.H. Brown, J. Han, and K.R. Chien Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells J. Biol. Chem. 273 1998 5423 5426
17. S. Kyoi et al. Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster Cardiovasc. Res. 69 2006 888 898
18. W. Wu, A. Muchir, J. Shan, G. Bonne, and H.J. Worman Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene Circulation 123 2011 53 61
19. J. Wen et al. Loss of Dact1 disrupts planar cell polarity signaling by altering dishevelled activity and leads to posterior malformation in mice J. Biol. Chem. 285 2010 11023 11030
20. P. Ybot-Gonzalez, D. Savery, D. Gerrelli, M. Signore, C.E. Mitchell, C.H. Faux, N.D. Greene, and A.J. Copp Convergent extension, planar-cell-polarity signalling and initiation of mouse neural tube closure Development 134 2007 789 799
21. M.T. Veeman, J.D. Axelrod, and R.T. Moon A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling Dev. Cell 5 2003 367 377
22. R. Suriben, S. Kivimae, D.A. Fisher, R.T. Moon, and B.N. Cheyette Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak Nat. Genet. 41 2009 977 985